Research output per year
Research output per year
Personal profile
Specialisation
Hematology (aggressive B-cel Non-Hodgkin Lymphoma)
Research interests
M.E.D. Chamuleau, MD PhD is an internist-hematologist with specific expertise in aggressive B-cell Non-Hodgkin lymphoma.
Regarding clinical research: she is the principal investigator of 3 clinical interventional HOVON trials for patients with MYC-driven lymphoma such as double hit lymphoma and Burkitt lymphoma (HOVON 127, 130 and 152). She is also the principal investigator of 2 non-interventional HOVON studies (HOVON 900 and 902) and supervising population-based research on lymphoma in collaboration with the IKNL (PhD D. Issa).
Regarding pre-clinical research she focuses on improving immuno-chemotherapy in aggressive B-cell Non-Hodgkin lymphomas by using hexabodies and duobodies (PhD H. van der Horst), by MYC modulation (PhD A.V. de Jonge) and response monitoring by liquid biopsies (S. Wang).
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature
de Jonge, A. V., Roosma, T. J. A., Houtenbos, I., Vasmel, W. L. E., van de Hem, K., de Boer, J. P., van Maanen, T., Lindauer-van der Werf, G., Beeker, A., Timmers, G. J., Schaar, C. G., Soesan, M., Poddighe, P. J., de Jong, D. & Chamuleau, M. E. D., Mar 2016, In: European Journal of Cancer. 55, p. 140-146 7 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access15 Citations (Scopus) -
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens
Oosten, L. E. M., Chamuleau, M. E. D., Thielen, F. W., de Wreede, L. C., Siemes, C., Doorduijn, J. K., Smeekes, O. S., Kersten, M. J., Hardi, L., Baars, J. W., Demandt, A. M. P., Stevens, W. B. C., Nijland, M., van Imhoff, G. W., Brouwer, R., Uyl-de Groot, C. A., Kluin, P. M., de Jong, D. & Veelken, H., 1 Feb 2018, In: Annals of hematology. 97, 2, p. 255-266 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access20 Citations (Scopus) -
Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial
Chamuleau, M. E. D., Nijland, M., Zijlstra, J. M., Mous, R., Lugtenburg, P. J., Dierickx, D., Imhoff, G. V., Vermaat, J., Bakunina, K., Marijt, E. W. A., Visser, O., Mandigers, C., Bilgin, Y., Burggraaff, C., Hoekstra, O., Jong, D. D. & Kersten, M. J., 21 Nov 2018, In: Blood. 132, Suppl 1, p. 786 1 p.Research output: Contribution to journal › Meeting Abstract › Academic
-
Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015
Dinmohamed, A. G., Issa, D. E., van der Poel, M. W. M., Schouten, H. C., Lugtenburg, P. J., Chamuleau, M. E. D., Zweegman, S. & Visser, O., 2017, In: Blood. 1, 21, p. 1839-1841 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access5 Citations (Scopus) -
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
Oostindie, S. C., van der Horst, H. J., Lindorfer, M. A., Cook, E. M., Tupitza, J. C., Zent, C. S., Burack, R., VanDerMeid, K. R., Strumane, K., Chamuleau, M. E. D., Mutis, T., de Jong, R. N., Schuurman, J., Breij, E. C. W., Beurskens, F. J., Parren, P. W. H. I. & Taylor, R. P., 31 Aug 2019, In: Haematologica. 104, 9, p. 1841-1852 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access31 Citations (Scopus)